EMR earnings / call / takeaways

EMR Q4 FY26 earnings call: key takeaways

What EMR said on its earnings call of November 4, 2026: results against expectations, what changed since last quarter, guidance and the questions analysts pressed on.

By Lician·November 4, 2026·AI-generated from the call transcript and Lician data

Emerson reported adjusted earnings per share of $1.86 for the fourth quarter, exceeding the consensus estimate of $1.85 (4:24)
The company raised its 2027 guidance, projecting adjusted earnings per share of $7.25. (4:24)

Results vs expectations

Metric	Consensus	Reported	Result
EPS	$1.85	–	–

What changed since last quarter

The company raised its 2027 adjusted EPS guidance to $7.25 from an unknown previous figure. (20:56)
Emerson expects 5% underlying sales growth in 2027, up from an unknown previous guidance. (20:56)
The CEO emphasized confidence in the company's future and highlighted the strength of the automation portfolio. (2:00)

Guidance

Metric	This call	Previous call
EPS	"- Full-year adjusted EPS of $7.25 " (4:24)	not captured
Free cash flow	"- Full-year free cash flow of $3.8 billion to $3.9 billion " (20:56)	not captured

What analysts pressed on

Whether Europe and China will continue to be headwinds for the company. (53:32)
Concerns about the impact of the Middle East conflict on business operations. (50:00)
Questions about the sustainability of the strong order growth and its impact on future performance. (24:59)

In their words

- "We are entering 2027 from a position of strength." (14:30)
- "We have a mid-single-digit outlook for the rest of Asia." (14:30)
- "We feel very good about the decision. (1:00:58)

Read the full transcript with the AI summary, or listen on the company's official webcast.

Every past call in full and transcript search come with Lician Pro.

Written by AI from the automatic transcript of the company's public webcast and Lician's earnings data. Each sentence cites the passage it comes from, and a sentence with a figure that is not in its sources was removed. Not investment advice.